EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Differentiating the roles of Mycobacterium tuberculosis substrate binding proteins, FecB and FecB2, in iron uptake

Rodger de Miranda, Bonnie J Cuthbert, Thaís Klevorn, Alex Chao, Jessica Mendoza, Mark Arbing, Paul J Sieminski, Kadamba Papavinasasundaram, Sumer Abdul-Hafiz, Sum Chan, Christopher M Sassetti, Sabine Ehrt und 1 weitere

PLOS Pathogens · 25.09.2023 · 19 (9) · e1011650

DOI: 10.1371/journal.ppat.1011650 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 25.09.2023. Verfasst von Rodger de Miranda und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology & Biochemistry, University of California Irvine, Irvine, California, United States of America. Hauptthemen laut MEDLINE: Iron, Mycobacterium tuberculosis. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH, Office of the Assistant Secretary of Defense for Health Affairs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis, poses a great threat to human health. With the emergence of drug resistant Mtb strains, new therapeutics are desperately needed. As iron is critical to the growth and survival of Mtb, mechanisms through which Mtb acquires host iron represent attractive therapeutic targets. Mtb scavenges host iron via Mtb siderophore-dependent and heme iron uptake pathways. While multiple studies describe the import of heme and ferric-siderophores and the export of apo-siderophores across the inner membrane, little is known about their transport across the periplasm and cell-wall environments. Mtb FecB and FecB2 are predicted periplasmic binding proteins implicated in host iron acquisition; however, their precise roles are not well understood. This study sought to differentiate the roles FecB and FecB2 play in Mtb iron acquisition. The crystallographic structures of Mtb FecB and FecB2 were determined to 2.0 Å and 2.2 Å resolution, respectively, and show distinct ligand binding pockets. In vitro ligand binding experiments for FecB and FecB2 were performed with heme and bacterial siderophores from Mtb and other species, revealing that both FecB and FecB2 bind heme, while only FecB binds the Mtb sideophore ferric-carboxymycobactin (Fe-cMB). Subsequent structure-guided mutagenesis of FecB identified a single glutamate residue—Glu339—that significantly contributes to Fe-cMB binding. A role for FecB in the Mtb siderophore-mediated iron acquisition pathway was corroborated by Mycobacterium smegmatis and Mtb pull-down assays, which revealed interactions between FecB and members of the mycobacterial siderophore export and import machinery. Similarly, pull-down assays with FecB2 confirms its role in heme uptake revealing interactions with a potential inner membrane heme importer. Due to ligand preference and protein partners, our data suggest that Mtb FecB plays a role in siderophore-dependent iron and heme acquisition pathways; in addition, we confirm that Mtb FecB2 is involved in heme uptake.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IronMycobacterium tuberculosisHumansSiderophoresLigandsBacterial ProteinsHeme

Substanzen

IronSiderophoresLigandsBacterial ProteinsHeme

Autor:innen und Institutionen

  • Department of Molecular Biology & Biochemistry, University of California Irvine, Irvine, California, United States of America.
  • Department of Microbiology and Immunology, Weill Cornell Medical College, New York, New York, United States of America.
  • UCLA-DOE Institute, UCLA, Los Angeles, Calofornia, United States of America.
  • Department of Microbiology and Physiological Systems, UMass Chan Medical School, Worcester, Massachusetts, United States of America.
  • Department of Pharmaceutical Sciences, University of California Irvine, Irvine, Califiornia, United States of America.

Förderung

  • NIAID NIH HHS
  • NIH
  • Office of the Assistant Secretary of Defense for Health Affairs

Zitieren

APA

de Miranda, R., Cuthbert, B. J., Klevorn, T., Chao, A., Mendoza, J., Arbing, M., Sieminski, P. J., Papavinasasundaram, K., Abdul-Hafiz, S., Chan, S., Sassetti, C. M., Ehrt, S., & Goulding, C. W. (2023). Differentiating the roles of Mycobacterium tuberculosis substrate binding proteins, FecB and FecB2, in iron uptake. PLOS Pathogens, 19(9), e1011650. https://doi.org/10.1371/journal.ppat.1011650

Vancouver

de Miranda R, Cuthbert BJ, Klevorn T, Chao A, Mendoza J, Arbing M, et al. Differentiating the roles of Mycobacterium tuberculosis substrate binding proteins, FecB and FecB2, in iron uptake. PLOS Pathogens. 2023;19(9):e1011650. doi:10.1371/journal.ppat.1011650

BibTeX
@article{deMiranda2023,
  author = {de Miranda, Rodger and Cuthbert, Bonnie J and Klevorn, Thaís and Chao, Alex and Mendoza, Jessica and Arbing, Mark and Sieminski, Paul J and Papavinasasundaram, Kadamba and Abdul-Hafiz, Sumer and Chan, Sum and Sassetti, Christopher M and Ehrt, Sabine and Goulding, Celia W},
  title = {Differentiating the roles of Mycobacterium tuberculosis substrate binding proteins, FecB and FecB2, in iron uptake},
  journal = {PLOS Pathogens},
  year = {2023},
  volume = {19},
  number = {9},
  pages = {e1011650},
  doi = {10.1371/journal.ppat.1011650}
}
Kostenlos starten →